Projects

Ing. Peter Makovický, PhD.

National

Current
  • The role of GPR180 in regulation of pancreatic beta cell function and pathogenesis of diabetes
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Reprogramming pancreatic ductal adenocarcinoma microenvironment towards immunotherapy
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Comparison between silibinin-conjugated gold nanospheres and nanobipyramids impacts on the treatment of liver fibrosis in vivo.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Employees